The incoming employees at the biopharmaceutical giant will zero in on mRNA, structural biology, and viral vaccine research ...

Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has bee ...

The long-running HIV market rivalry between Gilead Sciences and GSK is about to turn a new page this year as Gilead looks to ...

GSK plc (LSE/NYSE: GSK), a prominent pharmaceutical company with a market capitalization of $71.31 billion and an impressive gross profit margin of 72.39%, has announced that its new drug ...

GSK plc (LSE/NYSE: GSK), a prominent pharmaceutical company with a market capitalization of $71.29 billion and currently undervalued according to InvestingPro Fair Value metrics, has reached a ...

Both “pan” and “omni” mean “all,” and the distinction between omnisexuality and pansexuality is hazy. Some people use them interchangeably. Bisexuality, at its core, involves ...

Pharmaceutical giant GSK has inked a deal with the University of Oxford that will see it pump tens of millions of pounds into research for cancer vaccines. The FTSE 100 firm said under a ...

GSK’s share price has been pressured recently from several negative events, but this may leave a bargain to be had. I’ve investigated whether this is the case. When investing, your capital is ...

Meghan Markle has been described as acting 'like a Mean Girls teenager' and becoming 'cold' towards staff in a damning profile in Vanity Fair. The Duchess of Sussex would reportedly be 'warm and ...

Spero Therapeutics' tebipenem, an oral carbapenem for cUTIs, has high approval potential, supported by a successful phase 3 trial and a GSK licensing deal. The need for oral carbapenems is ...

Meghan Markle has been dubbed a “‘Mean Girls’ teenager” by a former staffer who made new allegations in a bombshell exposé on the duchess and her husband, Prince Harry. The report ...

Both assets are poised to enter registrational studies under accelerated approval pathways, according to Jefferies. GSK to Stay Out of Obesity—but not GLP-1s At JPM25 on Monday, GSK Chief Scientific ...